ArticleRSC advances2025
Electrochemical recognition of MMA-A biomarker for vitamin B
Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
For the first time, the efficient electroreduction and identification of methyl methacrylate (MMA) was achieved using a carbon fiber paper (CFP) electrode modified with polyaminothiazole-β-cyclodextrin (PAT-β-CD). The recognition capabilities of the β-CD/PAT/CFP and PAT/CFP electrodes were investigated using cyclic voltammetry, revealing the significant influence of β-CD on the observed electroanalytical behaviour. Specifically, a PAT-β-CD modified CFP electrode was fabricated by electropolymerizing aminothiazole, serving as a substrate for β-CD self-assembly through hydrogen bonding between the hydroxyl groups of β-CD and the nitrogen atoms of the polyaminothiazole ring system. This as-prepared electrode exhibited a novel electrochemical method for the identification of MMA. Notably, the final β-CD/PAT/CFP electrode demonstrated superior electrocatalytic activity towards MMA reduction under optimized conditions compared to bare CFP and other modified electrodes. This modified electrode displayed an extended linear concentration range of 10 nM to 270 nM and a low limit of detection (LOD) of 0.6 nM. Furthermore, the electrocatalyst demonstrated excellent stability, repeatability, and negligible interference from other species. Finally, the developed β-CD/PAT/CFP electrode was successfully applied for the quantitative determination of MMA in human urine samples.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.